551 related articles for article (PubMed ID: 26006245)
1. Soy and breast cancer: focus on angiogenesis.
Varinska L; Gal P; Mojzisova G; Mirossay L; Mojzis J
Int J Mol Sci; 2015 May; 16(5):11728-49. PubMed ID: 26006245
[TBL] [Abstract][Full Text] [Related]
2. Soy isoflavones suppress invasiveness of breast cancer cells by the inhibition of NF-kappaB/AP-1-dependent and -independent pathways.
Valachovicova T; Slivova V; Bergman H; Shuherk J; Sliva D
Int J Oncol; 2004 Nov; 25(5):1389-95. PubMed ID: 15492830
[TBL] [Abstract][Full Text] [Related]
3. Soy isoflavones and cancer prevention.
Sarkar FH; Li Y
Cancer Invest; 2003; 21(5):744-57. PubMed ID: 14628433
[TBL] [Abstract][Full Text] [Related]
4. Soy isoflavones and prostate cancer: a review of molecular mechanisms.
Mahmoud AM; Yang W; Bosland MC
J Steroid Biochem Mol Biol; 2014 Mar; 140():116-32. PubMed ID: 24373791
[TBL] [Abstract][Full Text] [Related]
5. Soy Isoflavones and Breast Cancer Cell Lines: Molecular Mechanisms and Future Perspectives.
Uifălean A; Schneider S; Ionescu C; Lalk M; Iuga CA
Molecules; 2015 Dec; 21(1):E13. PubMed ID: 26703550
[TBL] [Abstract][Full Text] [Related]
6. Antitumor and antiangiogenic activity of soy isoflavone genistein in mouse models of melanoma and breast cancer.
Farina HG; Pomies M; Alonso DF; Gomez DE
Oncol Rep; 2006 Oct; 16(4):885-91. PubMed ID: 16969510
[TBL] [Abstract][Full Text] [Related]
7. Soy for breast cancer survivors: a critical review of the literature.
Messina MJ; Loprinzi CL
J Nutr; 2001 Nov; 131(11 Suppl):3095S-108S. PubMed ID: 11694655
[TBL] [Abstract][Full Text] [Related]
8. Soy intake and cancer risk: a review of the in vitro and in vivo data.
Messina MJ; Persky V; Setchell KD; Barnes S
Nutr Cancer; 1994; 21(2):113-31. PubMed ID: 8058523
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms of cancer chemoprevention by soy isoflavone genistein.
Sarkar FH; Li Y
Cancer Metastasis Rev; 2002; 21(3-4):265-80. PubMed ID: 12549765
[TBL] [Abstract][Full Text] [Related]
10. Pleiotropic effects of genistein in metabolic, inflammatory, and malignant diseases.
Nagaraju GP; Zafar SF; El-Rayes BF
Nutr Rev; 2013 Aug; 71(8):562-72. PubMed ID: 23865800
[TBL] [Abstract][Full Text] [Related]
11. Suppression of VEGF-mediated autocrine and paracrine interactions between prostate cancer cells and vascular endothelial cells by soy isoflavones.
Guo Y; Wang S; Hoot DR; Clinton SK
J Nutr Biochem; 2007 Jun; 18(6):408-17. PubMed ID: 17142033
[TBL] [Abstract][Full Text] [Related]
12. Soy phytochemicals prevent orthotopic growth and metastasis of bladder cancer in mice by alterations of cancer cell proliferation and apoptosis and tumor angiogenesis.
Singh AV; Franke AA; Blackburn GL; Zhou JR
Cancer Res; 2006 Feb; 66(3):1851-8. PubMed ID: 16452247
[TBL] [Abstract][Full Text] [Related]
13. Soy extract inhibits mammary adenocarcinoma growth in a syngeneic mouse model.
Hewitt AL; Singletary KW
Cancer Lett; 2003 Mar; 192(2):133-43. PubMed ID: 12668277
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of murine bladder tumorigenesis by soy isoflavones via alterations in the cell cycle, apoptosis, and angiogenesis.
Zhou JR; Mukherjee P; Gugger ET; Tanaka T; Blackburn GL; Clinton SK
Cancer Res; 1998 Nov; 58(22):5231-8. PubMed ID: 9823337
[TBL] [Abstract][Full Text] [Related]
15. Influence of soy isoflavones in breast cancer angiogenesis: a multiplex glass ELISA approach.
Uifalean A; Rath H; Hammer E; Ionescu C; Iuga CA; Lalk M
J BUON; 2018 Dec; 23(7):53-59. PubMed ID: 30722112
[TBL] [Abstract][Full Text] [Related]
16. Antitumor and antiangiogenic activity of soy phytoestrogen on 7,12-dimethylbenz[alpha]anthracene-induced mammary tumors following ovariectomy in Sprague-Dawley rats.
Kang X; Jin S; Zhang Q
J Food Sci; 2009 Sep; 74(7):H237-42. PubMed ID: 19895476
[TBL] [Abstract][Full Text] [Related]
17. Soybean phytochemicals inhibit the growth of transplantable human prostate carcinoma and tumor angiogenesis in mice.
Zhou JR; Gugger ET; Tanaka T; Guo Y; Blackburn GL; Clinton SK
J Nutr; 1999 Sep; 129(9):1628-35. PubMed ID: 10460196
[TBL] [Abstract][Full Text] [Related]
18. Genistein and daidzein: different molecular effects on prostate cancer.
Adjakly M; Ngollo M; Boiteux JP; Bignon YJ; Guy L; Bernard-Gallon D
Anticancer Res; 2013 Jan; 33(1):39-44. PubMed ID: 23267126
[TBL] [Abstract][Full Text] [Related]
19. Soy Isoflavones in Integrative Oncology: Increased Efficacy and Decreased Toxicity of Cancer Therapy.
Sahin I; Bilir B; Ali S; Sahin K; Kucuk O
Integr Cancer Ther; 2019; 18():1534735419835310. PubMed ID: 30897972
[TBL] [Abstract][Full Text] [Related]
20. Kallistatin, a novel anti-angiogenesis agent, inhibits angiogenesis via inhibition of the NF-κB signaling pathway.
Huang KF; Huang XP; Xiao GQ; Yang HY; Lin JS; Diao Y
Biomed Pharmacother; 2014 May; 68(4):455-61. PubMed ID: 24721321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
